Bal Pharma Ltd. is in Pharmaceuticals & Drugs. It was incorporated in year 1987. The current market capitalisation stands Rs 55 Cr. The company is listed on the Bombay Stock Exchange (BSE) with the BSE code as 524824. and also listed on National Stock Exchange (NSE) with NSE code as BALPHARMA.
Bal Pharma Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and internationally. The offers prescription drugs, generics, OTC products, intravenous infusion products, and bulk actives. It provides anti-invectives’, pain management, respiratory care, and women's health products under the Aziwin, Ebay, Balvibe, MNF, Ocium, and Monogesic Plus Gel brands; diabetic care products under the Diabend and Diabend M Group brands; herbal/ayurvedic preparations targeting conditions, such as prostate enlargement, renal calculi, male infertility, women health, etc. under the Stonex, Ashwamed, Prostowin, Suswas, Menoleap, and Ayursulin brands; and cardiac care products under the Secremet and Servace brands. The also provides a range of APIs for therapeutic areas, such as anti-histamine, platelet inhibitor, anti-diabetic, anti convulsant, urinary incontinence, neuropathic pain, anti-allergy, anti-inflammatory, diuretic, acne treatment, etc.; and various formulations. The exports its products to Europe, Latin America, Africa, the Far East, the Middle East, and other world markets. Bal Pharma Limited was incorporated in 1987 and is based in Bengaluru, India.